The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 94.19%. However, over the past six months, we’ve seen a weaker performance of 34.50%. The price of YTEN fallen by 66.56% over the last 30 days. And in the last five days, it has surged by 85.14%.
The stock market performance of Yield10 Bioscience Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $3.29 on 05/11/23, while the lowest price during the same time frame was $0.18, recorded on 12/11/23.
52-week price history of YTEN Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Yield10 Bioscience Inc’s current trading price is -85.88% away from its 52-week high, while its distance from the 52-week low is 158.17%. The stock’s price range for this period has been between $0.18 and $3.29. The Basic Materials sector company’s shares saw a trading volume of about 104.94 million for the day, which was higher than the average daily volume of 2.47 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Yield10 Bioscience Inc (YTEN) has experienced a quarterly rise of 129.71% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.57M and boasts a workforce of 30 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2526, with a change in price of +0.0850. Similarly, Yield10 Bioscience Inc recorded 2,776,918 in trading volume during the last 100 days, posting a change of +23.29%.
YTEN’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for YTEN stands at 8.54. Similarly, the long-term debt-to-equity ratio is also 4.36.
YTEN Stock Stochastic Average
As of today, the raw stochastic average of Yield10 Bioscience Inc over the past 50 days is 49.63%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 46.55%. Additionally, the Stochastic %K and %D values for the company were 35.98% and 33.34%, respectively, over the past 20 days.
